Analytical Data
-
基因名
TWIST2
- Application
-
别名
bHLHa39; Class A basic helix-loop-helix Protein 39; Dermis expressed Protein 1; Dermis-expressed Protein 1; DERMO 1; Dermo-1; DERMO1; MGC117334; Twist 2; Twist homolog 2 (Drosophila); Twist homolog 2; Twist related bHLH Protein Dermo1; Twist related Protein 2; Twist-related Protein 2; Twist2; TWST2_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8WVJ9
-
表达区间
1-160 aa
-
氨基酸序列
MEEGSSSPVS PVDSLGTSEE ELERQPKRFG RKRRYSKKSS EDGSPTPGKR GKKGSPSAQS FEELQSQRIL ANVRERQRTQ SLNEAFAALR KIIPTLPSDK LSKIQTLKLA ARYIDFLYQV LQSDEMDNKM TSCSYVAHER LSYAFSVWRM EGAWSMSASH
-
分子量
18.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TWIST2 is a member of the Twist family of basic helix-loop-helix (bHLH) transcription factors, which play crucial roles in various biological processes, including cell differentiation, development, and epithelial-mesenchymal transition (EMT). Dysregulation of TWIST2 has been implicated in several pathological conditions, including congenital disorders and various forms of cancer. The study of TWIST2 recombinant proteins has gained significant attention as researchers aim to elucidate its functional mechanisms and potential therapeutic applications. By generating and characterizing recombinant TWIST2 proteins, scientists can investigate its interaction with target genes and regulatory pathways, furthering our understanding of its role in tumorigenesis and developmental biology. Moreover, recombinant TWIST2 proteins provide valuable tools for functional assays, enabling the exploration of its influence on cellular behaviors, such as migration and invasion. Understanding the structure-function relationship of TWIST2 is crucial, as it may reveal novel strategies for targeting TWIST2-related pathways in disease. Overall, research on TWIST2 recombinant proteins holds promise for advancing our knowledge of both fundamental biological processes and the development of innovative therapeutic approaches in regenerative medicine and oncology.
